Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451

MLA

Steve H. Krawczyk, et al. “Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451.” Antimicrobial Agents and Chemotherapy, vol. 58, no. 2, Aug. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48b208ecc462d0045cd0a382b2218120&authtype=sso&custid=ns315887.

APA

Steve H. Krawczyk, Marian Shen, Rowchanak Pakdaman, Choung U. Kim, William E. Delaney, Xiaoping Qi, Chin Tay, Hongmei Mo, Yang Tian, Huiling Yang, X. Christopher Sheng, Guofeng Cheng, Amoreena C. Corsa, Yujin Wang, Betty Peng, Margaret Robinson, & Chris Yang. (2013). Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451. Antimicrobial Agents and Chemotherapy, 58(2).

Chicago

Steve H. Krawczyk, Marian Shen, Rowchanak Pakdaman, Choung U. Kim, William E. Delaney, Xiaoping Qi, Chin Tay, et al. 2013. “Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451.” Antimicrobial Agents and Chemotherapy 58 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48b208ecc462d0045cd0a382b2218120&authtype=sso&custid=ns315887.